Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus

AIM: To investigate the cost-effectiveness of liraglutide as add-on to metformin vs. glimepiride or sitagliptin in patients with Type 2 diabetes uncontrolled with first-line metformin. METHODS: Data were sourced from a clinical trial comparing liraglutide vs. glimepiride, both in combination with me...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, M J, Chubb, B D, Smith, I C, Valentine, W J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378710/
https://www.ncbi.nlm.nih.gov/pubmed/21883438
http://dx.doi.org/10.1111/j.1464-5491.2011.03429.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378710/
https://www.ncbi.nlm.nih.gov/pubmed/21883438
http://dx.doi.org/10.1111/j.1464-5491.2011.03429.x

Ejemplares similares